284
Participants
Start Date
September 30, 2008
Primary Completion Date
September 30, 2011
Study Completion Date
November 30, 2011
Cyclosporine Inhalation Solution (CIS)
Cyclosporine (USP) Inhalation Solution; 300mg/4.8 mL in propylene glycol (USP) at a concentration of 62.5 mg/mL; 3 times a week for study duration (up to 3 years)
New York Presbyterian Hospital, Columbia University Med. Ctr., New York
University of Pittsburgh Medical Center, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
University of Maryland, Baltimore
Inova Fairfax Hospital, Falls Church
Mayo Clinic, Jacksonville
University of Florida Health Sciences Center, Gainesville
Tampa General Hospital, Tampa
Cleveland Clinic, Cleveland
Indiana Methodist Research Institute, Indianapolis
University of Minnesota, Minneapolis
Loyola University Hospital, Maywood
University of Chicago Hospitals, Chicago
Baylor College of Medicine, Houston
University of Colorado Health Sciences Center, Denver
UCLA School of Medicine, Los Angeles
University of California, San Francisco, San Francisco
Stanford University Medical Center, Stanford
University of Toronto, Toronto
Lead Sponsor
APT Pharmaceuticals, Inc.
INDUSTRY